Onconetix, Inc. Conversion of Stock, Amount Issued
Onconetix, Inc. (ONCO) reported Conversion of Stock, Amount Issued of $384.84 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockAmountIssued1 · last filed 2026-08-13
- Onconetix, Inc. conversion of stock, amount issued for the quarter ending 2026-03-31 was $384.84K.
- Onconetix, Inc. conversion of stock, amount issued for the quarter ending 2024-12-31 was $0.00.
- Onconetix, Inc. conversion of stock, amount issued for fiscal 2024 was $64.24M, a 1740.58% increase from fiscal 2023.
- Onconetix, Inc. conversion of stock, amount issued for fiscal 2023 was $3.49M.
| Period end | Conversion of Stock, Amount Issued 3 month | Conversion of Stock, Amount Issued 9 month | Conversion of Stock, Amount Issued 12 month |
|---|---|---|---|
| 2026-03-31 | $384.84K 10-Q · filed 2026-08-13 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $64.24M 10-K · filed 2026-03-13 | |
| 2024-09-30 | $64.24M 10-Q · filed 2025-11-13 | ||
| 2023-12-31 | $3.49M 10-K · filed 2024-04-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |